ICTA - Publications

International Center For Technology Assessment

Projects

Home | About Us | Press Room | Publications | Contact Us

Global Warming & the Environment
Patent Watch
Nanotechnology
Human Biotechnology
Corporate Accountability & Economics

Publications

Global Warming & the Environment

Nanotechnology

CTA Staff Attorney George Kimbrell, Governing Nanobiotechnology: Principles for Oversight and Using Existing Frameworks, Journal of Law, Medicine & Ethics (JLME), Nanobio Symposium: Developing Oversight Approaches to Nanobiotechnology: The Lessons of History (forthcoming 2009).

Nanotechnology and the National Environmental Policy Act, George Kimbrell co-author, American Bar Association, Section of Environment, Energy, and Resources, ABA SEER Nanotechnology Project (forthcoming 2009).

CTA Staff Attorney George Kimbrell presentation, Nanotechnology and Nano-Products: New For Hype But Not for Oversight, American Bar Association, TTEL Spring Meeting, Size Does Matter: The Impact of Nanotechnology on Human Health and the Environment, Phoenix, AZ (April 4, 2009).

CTA Staff Attorney George Kimbrell presentation, Surveying the National Environmental Policy Act and the Emerging Issues of Climate Change, Genetic Engineering and Nanotechnology, American Bar Association, 38th Annual Conference on Environmental Law: The Next Generation, Keystone, CO (March 14, 2009).

CTA Policy Director Jaydee Hanson, Principles for the Oversight of Nanotechnologies and other emerging technologies, World Council of Churches, Bossey Conference Center, Genève, Switzerland (Dec.2, 2008)

The Environmental Hazards of Nanomaterials, Commentary, Nanotechnology: Ethics and Society, Debra Bennett-Woods, Perspectives in Nanotechnology Series, CRC Press (2008).

CTA Policy Director Jaydee Hanson, Converging Technologies: Human Genetics, Nano-Medicine, and Synthetic Biology, presentation at BANG: From What Next? to What If? - toward a global CSO response to structural and technological convergence, Montpellier, France (November 23, 2008)

CTA Policy Director Jaydee Hanson, Ethical Concerns with Synthetic Biology, Synthetic Biology Teach-in, Mission Bay, San Francisco, CA (Nov. 13, 2008)

CTA Policy Director Jaydee Hanson, Nano Medicine or Nano Hype?, US Food and Drug Administration Meeting on Nanotechnology (Sept. 8, 2008)

CTA Staff Attorney George Kimbrell presentation, Going Slow with Emerging Technologies, Gordon Research Conference, GRC on Science & Technology Policy, Implementation of Governance Activities: Civilian Issues, Big Sky, MT (August 22, 2008).

CTA Staff Attorney George Kimbrell, Nanotechnology: EPA Regulatory and Litigation Update, Environmental Law Institute, ELI Seminar, Washington, D.C., (July 22, 2008).

CTA Policy Director Jaydee Hanson, The Ethical Implications of Synthetic Life: Nanotechnology meets Victor Frankenstein, University of Maryland-Baltimore County, (April 2, 2008)

Dust-Up: The Great Nanotech Debate, Op-Ed series, Los Angeles Times, (Feb 25-29, 2008).

CTA Staff Attorney George Kimbrell, Innovative Approaches to Nanotechnology Environmental Governance, NanoGovernance 2008, George Washington Law School, (February 12, 2008).

Principles for the Oversight of Nanotechnologies and Nanomaterials
January 31, 2008

The undersigned, a broad coalition of civil society, public interest, environmental and labor organizations concerned about various aspects of nanotechnology's human health, environmental, social, ethical, and other impacts, submit the following Declaration, Principles for the Oversight of Nanotechnologies and Nanomaterials.

Governments, universities, and businesses around the world are racing to commercialize nanotechnologies and nanomaterials. Already, hundreds of consumer products either contain nanomaterials (nano-scale chemicals) in the finished product, or are made using nanotechnologies. At the same time, mounting evidence indicates that this new materials revolution poses significant health, safety, and environmental hazards as well as profound social, economic, and ethical challenges. Those speeding the commercialization of nanotechnologies have barely begun the research needed both to clarify and reduce risks and to develop urgently needed ethical, legal and regulatory oversight mechanisms. These mechanisms are required if we are to avoid repeating failures of past 'wonder' materials and technologies.

The current situation does not give us hope that we will 'get it right' with nanotechnology. Manufacturing and laboratory settings operate without proper safety guidance or protection measures. Consumers are involuntarily exposed to unlabeled nanomaterial ingredients in products, without being informed of potential risks. Nanomaterials are disposed of and released into the environment despite unknown impacts and inadequate means to detect, track or remove the new materials. Governments and industry developers of nanotechnologies provide few meaningful opportunities for informed public participation in discussions and decisions about how, or even whether, to proceed with the 'nano'-ization of the world.

This document declares eight fundamental principles that we believe must provide the foundation for adequate and effective oversight and assessment of the emerging field of nanotechnology, including those nanomaterials that are already in widespread commercial use.

The Principles

I. A Precautionary Foundation

II. Mandatory Nano-specific Regulations

III. Health and Safety of the Public and Workers

IV. Environmental Protection

V. Transparency

VI. Public Participation

VII. Inclusion of Broader Impacts

VIII. Manufacturer Liability

A precautionary approach is fundamental. A precautionary approach requires mandatory, nano-specific oversight mechanisms to account for the unique characteristics of the materials. Within those mechanisms, the protection of public health and worker safety requires a committed focus on critical risk research and immediate action to mitigate potential exposures until safety is demonstrated. Similar emphasis and action must be taken with regard to safeguarding the natural environment. Throughout, oversight must be transparent and provide public access to information regarding decision-making processes, safety testing and products. Open, meaningful and full public participation at every level is essential. These discussions and analyses should include consideration of nanotechnology's wide-ranging effects, including ethical and social impacts. Finally, developers and manufacturers must be stewards responsible for the safety and effectiveness of their processes and products, and retain liability for any adverse impacts stemming from them. Governmental bodies, organizations, and relevant parties should implement comprehensive oversight mechanisms enacting, incorporating and internalizing these basic principles as soon as possible.

American Bar Association Meeting Presentation on Nanotechnology, Nanomaterials in Consumer Products, and FDA Regulation
August 12, 2007

CTA Staff Attorney George Kimbrell spoke on nanotechnology oversight issues at the American Bar Association's 2007 conference in San Francisco, CA, August 12, 2007.

Oversight of Nanomaterials in Consumer Products
February 8, 2007

CTA Staff Attorney George Kimbrell spoke on nanotechnology oversight issues at Intertech Pira's Regulation of Nanotechnology in Consumer Products Conference in Washington, D.C., February 8-9, 2007.

Nanotechnology and Toxic Torts
December 11, 2006

CTA Staff Attorney George Kimbrell addressed plaintiff and defense toxic tort attorneys from around the country at the 2006 HarrisMartin Publishing's Cutting Edge Toxic Tort conference in Scottsdale, AZ on the human health and environmental hazards of nanomaterials and the possibility of future nano-based toxic torts.

Nanomaterials in Consumer Products:It's a Small (and Unregulated) World After All
December 1, 2006

CTA Staff Attorney George Kimbrell provided this commentary to the University of Chicago-Kent School of Law's Center on Nanotechnology and Society on Nanomaterials in Consumer Products and FDA's first Public Meeting on Nanotechnology.

Nanomaterials in the Waste Stream
October 6, 2006

Nanomaterials are being integrated into consumer products at an alarming rate, where they are traveling through the household waste stream and into the environment. Their impacts are largely unknown, but existing studies raise red flags concerning some manufactured nanoparticles' mobility and interactions with microorganisms. CTA Staff Attorney George Kimbrell spoke at the 2006 National Association of Clean Water Agencies (NACWA) conference about these concerns.

Carpe Diem: Now is the Time to Consider Nanotechnology's Impact on the Human Condition
October 1, 2006

CTA Human Genetics Director Jaydee Hanson provided this commentary to the University of Chicago-Kent School of Law's Center on Nanotechnology and Society discussing nanotechnology's impacts on the human condition.

Nanomaterials in Sunscreens and Cosmetics
September 13, 2006

CTA Staff Attorney George Kimbrell spoke at the 2006 Health and Beauty America (HBA) Expo's Regulatory Summit on the regulation of nanomaterials used in personal care products. Held at the Jacob K. Javits Center in New York City, the HBA Expo is the largest personal care product conference in the world. Mr. Kimbrell was the only non-industry speaker invited to the Summit (webcast available here).

Nanomaterials in Consumer Products and FDA Regulation: Regulatory Challenges and Necessary Amendments
September 1, 2006

Nanotechnology Law and Business, the leading peer reviewed journal devoted to the legal, business, and policy aspects of small scale technologies, publishes an article on CTA's FDA petition and related regulatory issues written by CTA Staff Attorney George Kimbrell, 3 Nanotech L. & Bus. 328 (Fall 2006).

Nanotechnology and Biotechnology in Society (NABIS) 2006 Conference
August 10, 2006

The 2006 Nano and Bio In Society conference brought together leading scientists, academics, industry representatives, government officials, and non-profit organizations to discuss the various impacts these technologies are having on our planet and society. CTA Staff Attorney George Kimbrell spoke on U.S. regulation of nanomaterials in consumer products.

Friends of the Earth publishes report on use of nanotechnology in cosmetics
May 16, 2006

Some of the biggest names in cosmetics, including L'Oreal, Revlon and Estee Lauder, continue to sell products containing nano-scale ingredients despite growing evidence that nanomaterials can be toxic to humans, according to a report released today by Friends of the Earth.

The report, titled "Nanomaterials, Sunscreens and Cosmetics: Small Ingredients, Big Risks", details the extensive use of newly developed and poorly understood substances called nanomaterials in more than 116 sunscreens, cosmetics and personal care products currently on the market, despite a lack of independent safety assessment and regulation. The report also surveys a growing body of scientific research showing that many types of nanoparticles pose risks to consumers, workers and the environment. CTA staffers contributed to the report, which was released in conjunction with CTA's legal petition to FDA, the first-ever legal action on the risks of nanotechnology.

Lessons for Nanotechnology from Agricultural Biotechnology
November 23, 2005

CTA Human Genetic Director Jaydee Hanson crafted this commentary for the University of Chicago-Kent School of Law's Center on Nanotechnology and Society on the Lessons for Nanotechnology from Biotechnology and discussing a Fall 2005 Conference held on that topic at Michigan State University.

Patent Watch

Fetal Dependent Patents: An Interim Report
October 5, 2005

This report examines the extent that patents have promoted the commercialization of human fetal organs and other human fetal tissue. The period 1991-2001 saw an explosion in the number of US patents that rely upon or depend upon the ready availablity of fetal tissue in this country.

The report concludes that the United States Patent and Trademark Office should not neglect to enforce the public policy/morality prong of 35 USC 101 in the face of evidence that human body parts have become the subject of issued US Patent claims.

Legal Challenge to U.S. Patenting of Animals (Executive Summary)
February 25, 2004
CTA and the American Anti-Vivisection Society demand the cancellation of a patent granted to the University of Texas for a beagle with a suppressed immune system.
View the Request for Reexamination.

Animal Patenting Fact Sheet
February 24, 2004
Compiled by CTA's Patent Watch Program and the American Anti-Vivisection Society.

Executive Summary of Patent Watch's Discovery of the First US Patent for Reproductive Human Cloning
May 16, 2002
Patent Watch discovers that the United States has granted a patent for a human cloning techniques, as well as for any resulting embryos, fetuses, and children.
View the Press Release.
View the Patent.

Biocolonization: The Patenting of Life and the Global Market in Body Parts
July 15, 1996
A chapter written by CTA Executive Director Andrew Kimbrell from The Case Against the Global Economy and a Turn Toward the Local (Sierra Club Books, 1996).